Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-24

Clinical Trial Update: Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease

View source ↗

Summary

Clinical trial update describing the validation of a proteomic biomarker to predict progression of chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Angel Argiles | Conditions: Chronic Kidney Disease(CKD), Progression, Disease | Status: ACTIVE_NOT_RECRUITING